JAMJOOM PHARMACEUTICALS FACTORY CO. financial statements, including revenue, expenses, profit, and loss
The total revenue of 4015 for the last quarter is 207.86 M SAR, and it's 28.97% lower compared to the previous quarter. The net income of Q4 23 is 44.48 M SAR.